MP
BHVN

Mangrove Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Mangrove Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-89,182
Closed -$13.2M – 458
2022
Q3 		$13.2M Hold
89,182
– – 0.77% 30
2022
Q2 		$13M Buy
+89,182
New +$13M 0.64% 27